Currently available therapies such as niacin and PCSK9 inhibitors such as Repatha (evolocumab) and Praluent (alirocumab) can reduce Lp (a) levels, but their impact is modest. Another challenge in ...

Brigham and Women's Hospital investigators link very high lipoprotein(a) with a higher 30-year risk of major cardiovascular ...

Very high Lp(a) also correlated with higher risks of ischemic stroke and cardiovascular mortality in the Women’s Health Study ...

Find out how lipoprotein(a) screening identifies women at long term cardiovascular risk and supports earlier prevention ...

A new study finds that elevated levels of Lp(a) may increase the risk of death from cardiovascular disease in some patie ...

Elevated levels of lipoprotein (a) is a genetic disease that causes cardiovascular disease. Steven Nissen, M.D., addresses why it’s important to find treatments for this genetic risk factor.

Comparing extremes of the spectrum, multivariable analyses generally showed significantly higher risks for patients with high ...

Among women, very high levels of lipoprotein(a) are associated with an increased risk for future cardiovascular disea ...

Lipoprotein(a), a fatty particle, can clog arteries just as surely as cholesterol but often goes undetected, striking seemingly healthy people unaware of the danger.

Dear Dr. Roach: I'm a healthy 50-year-old woman. I asked my doctor to test me for Lipoprotein(a) after reading about it. My level was high, at 41 mg/dL. My doctor told me that it didn't need to be ...

Researchers from University of California San Diego School of Medicine have found that testing for lipoprotein(a) - a genetic risk factor for heart disease - remains uncommon in the United States, ...